Zhiyi Biotech's Next generation probiotic AKK AM06 has obtained GRAS certification from the United States

Zhiyi Biotech Successfully Completes Phase I Clinical Trial of SK10 for the Treatment of Chemotherapy-induced Diarrhea

News: The Phase III clinical trial of SK08 was approved and subject initiation recruitment

Zhiyi Biotech Raised Nearly CNY100 Million C Round of Financing to Accelerate the Phase III clinical research